EXUMA BIOTECH
EXUMA Biotech is a clinical-stage biotechnology company discovering and developing Chimeric Antigen Receptor (CAR)-T cell products for solid tumors. They develop new tools for the patient’s immune system to fight various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, and others. It was founded in 2015 and headquartered in Grand Cayman, Midland.
EXUMA BIOTECH
Industry:
Big Data Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Grand Cayman, Midland, Cayman Islands
Country:
Cayman Islands
Website Url:
http://www.exumabio.com
Total Employee:
11+
Status:
Active
Contact:
1-345-232-0566
Total Funding:
107 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Abexxa Biologics
Abexxa Biologics is a biopharmaceutical company that focuses on discovering and developing breakthrough antibody-based drugs.
Renovare Environmental
Renovare Environmental uses Green Technology and Big Data to dispose of organic waste, cut costs, and drive sustainability.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
Garner Health
Garner Health is a technology-driven platform providing healthcare services and helping people search for doctors.
Aitia
Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
MedAnswers
A health tech company disrupting how those struggling to conceive access specialty fertility care through the best of science and tech.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
OM1
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Orchid
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Valo Health
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Y-mAbs Therapeutics
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.
Current Advisors List
Board_member
2021-12-01
Current Employees Featured
James Samuels Chief Financial Officer @ Exuma Biotech
Chief Financial Officer
2019-06-01
Gregory Frost Chairman & CEO @ Exuma Biotech
Chairman & CEO
2015-12-01
Founder
Investors List
Americo Financial Life and Annuity
Americo Financial Life and Annuity investment in Series B - Exuma Biotech
MSD Partners
MSD Partners investment in Series B - Exuma Biotech
F1 BioVentures
F1 BioVentures investment in Series B - Exuma Biotech
Shanghai Sinobioway Sunterra Biotechnology
Shanghai Sinobioway Sunterra Biotechnology investment in Venture Round - Exuma Biotech
Sinobioway Group
Sinobioway Group investment in Series A - Exuma Biotech
BioAtla
BioAtla investment in Series A - Exuma Biotech
F1 BioVentures
F1 BioVentures investment in Series A - Exuma Biotech
SunTerra Capital
SunTerra Capital investment in Series A - Exuma Biotech
Official Site Inspections
http://www.exumabio.com Semrush global rank: 10.27 M Semrush visits lastest month: 14
- Host name: cloudproxy10079.sucuri.net
- IP address: 192.124.249.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exuma Biotech"
Our Company - EXUMA Biotech
Vice President of Finance & Controller. Mr. Yan is a certified public accountant with over 25 years of experience in finance & accounting. He joined EXUMA Biotech in 2017 and currently serves as its Vice President of Finance & …See details»
EXUMA Biotech - Clinical-Stage Biotechnology Company
Apr 17, 2023 A dedicated synthetic lymph node as a CAR production line. EXUMA’s rPOC Subcutaneous (SC) platform has been designed to optimize efficacy and safety, while eliminating the need for lymphodepleting …See details»
Exuma Biotech - Crunchbase Company Profile
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.See details»
Press Releases & Mentions - exumabio.com
Mar 12, 2020 Additionally, the company has now aligned management with its international subsidiaries under one cohesive global organization (www.exumabio.com), to better reflect its …See details»
EXUMA Biotech Corp. - Drug pipelines, Patents, Clinical trials
Jan 4, 2025 For more information, visit exumabio.com and connect with us on LinkedIn and Twitter (@ExumaBiotech). Contact: Gregory R. Wade, Ph.D. Chief Business Officer & Head of …See details»
EXUMA Biotech - LinkedIn
EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, The company has rapidly built its …See details»
EXUMA Biotech - LinkedIn
EXUMA Biotech | 1,722 followers on LinkedIn. EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. …See details»
EXUMA Biotech - Overview, News & Similar companies - ZoomInfo
Www.exumabio.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. EXUMA Biotech Presents Early Clinical and Translational …See details»
EXUMA Biotech | 领英 - 领英 (中国)
EXUMA Biotech | 在领英上有 1,719 位关注者。EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. …See details»
Exuma Biotech - Craft
West Palm Beach, FL HQ. United States. 625 N Flagler Dr #625. Sacramento, CA. United States. 400 R St. George Town, George Town. Cayman Islands. Strathvale House, 90 N Church StSee details»
Exuma Biotech (fka F1 Oncology) - VentureRadar
"EXUMA Biotech Corp is a private Delaware corporation formed in November 2015 with operations in West Palm Beach, Florida and international affiliates in the Cayman Islands and …See details»
F1 Oncology Changes Name To EXUMA Biotech; Announces New …
Mar 12, 2020 Additionally, the company has now aligned management with its international subsidiaries under one cohesive global organization (www.exumabio.com), to better reflect its …See details»
Exuma Biotech CEO and Key Executive Team | Craft.co
Exuma Biotech's Chairman & CEO is Gregory Frost. Other executives include Sid Kerkar, VP Oncology, Research & Development; Wendy Zhang, VP Alliance Operations, Shanghai and 5 …See details»
March 12, 2020 - exumabio.com
Cohesive global organization (www.exumabio.com), to better reflect its new business model. “We are ... exumabio.com. Media Contact: Susan Roberts (202) 779-0929 sr@roberts …See details»
EXUMA Biotech Corp. (EXUMA Biotech Corp.) - 药物管线_专利_临 …
WEST PALM BEACH, Fla., April 17, 2023 /PRNewswire/ -- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for …See details»
F1 Oncology Changes Name To EXUMA Biotech; Announces New …
Mar 12, 2020 WEST PALM BEACH, Fla., March 12, 2020 /PRNewswire/ -- EXUMA Biotech Corp. (formerly F1 Oncology), a clinical-stage biotechnology company discovering and …See details»
EXUMA Biotech Inks $19M Series B Round - vcnewsdaily.com
Additionally, the company has now aligned management with its international subsidiaries under one cohesive global organization (www.exumabio.com), to better reflect its new business …See details»
Our Science - EXUMA Biotech
In 2015, EXUMA initiated ambitious efforts to discover platform technologies that could enablecell and gene therapies to deliver their full potential to patients. EXUMA’s Platforms may Enhance …See details»
Team - Gossamer Bio
Mr. Boerneke has served as General Counsel and Secretary of Gossamer Bio since 2021 and as our Associate General Counsel since April 2018. Previously, from 2015 to 2018, Mr. Boerneke …See details»
EXUMA Biotech Completes Series B2 to Advance Novel Cell
Dec 21, 2021 West Palm Beach, Fl., – December 21st, 2021- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and …See details»